Dr. Husain is a lung cancer medical oncologist pursuing a translational career in cancer therapeutic strategies in solid tumor malignancies. His passion is to be involved in early drug development, and his goal is to develop a translational laboratory for biomarker validation and drug testing in in vitro and in vivo models that can form the basis for early phase clinical trials. He works very closely to characterize technology development in the circulating tumor DNA space and applications about its utility. He has also recently been involved in understanding mechanisms of resistance to anti-EGFR directed therapies and further understanding the mechanisms of immunogenic cell death in cancer cells.
